Future of Beta Cells in Adults With Genetic Abnormality Behind Neonatal Diabetes (GLUCONEO)

Assistance Publique - Hôpitaux de Paris

Status: Unknown

Conditions: Diabetes

Study type: Observational

Funder types: Other

Identifiers

NCT02072551

GLUCONEO

Details and patient eligibility

About

The main objective of this study is to evaluate Beta cells in patients with a neonotal diabetes linked to a genetic abnormality Metabolic caracteristics will described using a transversal cohort study.

Enrollment: 17 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age : 18 à 65 year
• diabetic patient with a neonatal diabetis (before 1 year old) and need for insuline or patient with a relative having neonatal diabetis

Exclusion criteria

Diabète induit (médicaments - ex corticoïdes) ou syndromique

• infection
• cancer
• pegnancy

Trial design

17 participants in 2 patient groups

Adult with neonatal diabetes

Description:

Adult with neonatal diabetes (before 1 year ) and need for insulin

non diabetic adults with a relative with neonatal diabetes